Showing 1 - 8 results of 8 for search 'Michael P. Hay', query time: 0.04s Refine Results
  1. 1
    Studies Towards Hypoxia-Activated Prodrugs of PARP Inhibitors

    Studies Towards Hypoxia-Activated Prodrugs of PARP Inhibitors by Benjamin D. Dickson, Way Wua Wong, William R. Wilson, Michael P. Hay

    Published 2019-04-01
    Get full text
    Article
  2. 2
    Synthesis, structure, and reactivity of the 2,3- and 3,4-N-phenyl imides and the 3-N-phenyl amide of all-cis-cyclopentane-1,2,3,4-tetracarboxylic acid

    Synthesis, structure, and reactivity of the 2,3- and 3,4-N-phenyl imides and the 3-N-phenyl amide of all-cis-cyclopentane-1,2,3,4-tetracarboxylic acid by N. Guy Billett, Andrew T. Phillis, Lyndsay Main, Brian K. Nicholson, William A. Denny, Michael P. Hay

    Published 2005-09-01
    Get full text
    Article
  3. 3
    Spin Trapping Hydroxyl and Aryl Radicals of One-Electron Reduced Anticancer Benzotriazine 1,4-Dioxides

    Spin Trapping Hydroxyl and Aryl Radicals of One-Electron Reduced Anticancer Benzotriazine 1,4-Dioxides by Wen Qi, Pooja Yadav, Cho R. Hong, Ralph J. Stevenson, Michael P. Hay, Robert F. Anderson

    Published 2022-01-01
    Get full text
    Article
  4. 4
    Design, Synthesis and Anticancer Evaluation of Nitroimidazole Radiosensitisers

    Design, Synthesis and Anticancer Evaluation of Nitroimidazole Radiosensitisers by Lydia P. Liew, Avik Shome, Way W. Wong, Cho R. Hong, Kevin O. Hicks, Stephen M. F. Jamieson, Michael P. Hay

    Published 2023-05-01
    Get full text
    Article
  5. 5
    Patient-Derived Xenograft and Organoid Models for Precision Medicine Targeting of the Tumour Microenvironment in Head and Neck Cancer

    Patient-Derived Xenograft and Organoid Models for Precision Medicine Targeting of the Tumour Microenvironment in Head and Neck Cancer by Tet Woo Lee, Amy Lai, Julia K. Harms, Dean C. Singleton, Benjamin D. Dickson, Andrew M. J. Macann, Michael P. Hay, Stephen M. F. Jamieson

    Published 2020-12-01
    Get full text
    Article
  6. 6
    Benzotriazine Di-Oxide Prodrugs for Exploiting Hypoxia and Low Extracellular pH in Tumors

    Benzotriazine Di-Oxide Prodrugs for Exploiting Hypoxia and Low Extracellular pH in Tumors by Michael P. Hay, Hong Nam Shin, Way Wua Wong, Wan Wan Sahimi, Aaron T.D. Vaz, Pooja Yadav, Robert F. Anderson, Kevin O. Hicks, William R. Wilson

    Published 2019-07-01
    Get full text
    Article
  7. 7
    Subcellular Location of Tirapazamine Reduction Dramatically Affects Aerobic but Not Anoxic Cytotoxicity

    Subcellular Location of Tirapazamine Reduction Dramatically Affects Aerobic but Not Anoxic Cytotoxicity by Chris P. Guise, Maria R. Abbattista, Robert F. Anderson, Dan Li, Rana Taghipouran, Angela Tsai, Su Jung Lee, Jeff B. Smaill, William A. Denny, Michael P. Hay, William R. Wilson, Kevin O. Hicks, Adam V. Patterson

    Published 2020-10-01
    Get full text
    Article
  8. 8
    Reductive Metabolism Influences the Toxicity and Pharmacokinetics of the Hypoxia-Targeted Benzotriazine Di-Oxide Anticancer Agent SN30000 in Mice

    Reductive Metabolism Influences the Toxicity and Pharmacokinetics of the Hypoxia-Targeted Benzotriazine Di-Oxide Anticancer Agent SN30000 in Mice by Yongchuan Gu, Tony T.-A. Chang, Jingli Wang, Jagdish K. Jaiswal, David Edwards, Noel J. Downes, H. D. Sarath Liyanage, Courtney R. H. Lynch, Frederik B. Pruijn, Anthony J. R. Hickey, Michael P. Hay, William R. Wilson, Kevin O. Hicks

    Published 2017-08-01
    Get full text
    Article

Search Tools: